Anthony Vendetti
Stock Analyst at Maxim Group
(4.39)
# 334
Out of 4,945 analysts
82
Total ratings
31.08%
Success rate
52.12%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Buy | $50 → $65 | $57.25 | +13.54% | 8 | Aug 8, 2025 | |
| NEPH Nephros | Maintains: Buy | $4.5 → $6 | $4.27 | +40.52% | 1 | Aug 8, 2025 | |
| LSF Laird Superfood | Initiates: Buy | $12 | $6.15 | +95.28% | 1 | Jun 30, 2025 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $60 → $30 | $5.79 | +418.13% | 4 | May 21, 2025 | |
| NUTX Nutex Health | Maintains: Buy | $100 → $225 | $85.32 | +163.71% | 5 | May 20, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $14 → $10 | $3.44 | +191.01% | 6 | May 19, 2025 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $10 → $5 | $1.86 | +168.82% | 8 | May 8, 2025 | |
| AMIX Autonomix Medical | Initiates: Buy | $5 | $1.10 | +354.55% | 1 | Apr 29, 2025 | |
| BIAF bioAffinity Technologies | Downgrades: Hold | n/a | $0.23 | - | 2 | Apr 1, 2025 | |
| NXL Nexalin Technology | Upgrades: Buy | $5 | $0.76 | +557.89% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.78 | +237.08% | 1 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $9.14 | +31.29% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.05 | - | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $1.40 | +471.43% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.90 | - | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $15.68 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $2.53 | +2,272.48% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.08 | +23.76% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.04 | +383.09% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.80 | +2,912.43% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.89 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $0.93 | +114.02% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $0.80 | +15,573.98% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.39 | +1,702.27% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $39.79 | -37.17% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.38 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $3,500 | $2.05 | +170,324.11% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $2.85 | +75.75% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.13 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.87 | +244.87% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $16.18 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $120,000 | $3.93 | +3,053,335.11% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $45.15 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.73 | +99,087.22% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.35 | -51.69% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.87 | - | 1 | May 31, 2016 |
Celsius Holdings
Aug 8, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $57.25
Upside: +13.54%
Nephros
Aug 8, 2025
Maintains: Buy
Price Target: $4.5 → $6
Current: $4.27
Upside: +40.52%
Laird Superfood
Jun 30, 2025
Initiates: Buy
Price Target: $12
Current: $6.15
Upside: +95.28%
Dermata Therapeutics
May 21, 2025
Maintains: Buy
Price Target: $60 → $30
Current: $5.79
Upside: +418.13%
Nutex Health
May 20, 2025
Maintains: Buy
Price Target: $100 → $225
Current: $85.32
Upside: +163.71%
Sensus Healthcare
May 19, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $3.44
Upside: +191.01%
The Hain Celestial Group
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.86
Upside: +168.82%
Autonomix Medical
Apr 29, 2025
Initiates: Buy
Price Target: $5
Current: $1.10
Upside: +354.55%
bioAffinity Technologies
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.23
Upside: -
Nexalin Technology
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $0.76
Upside: +557.89%
Feb 27, 2025
Initiates: Buy
Price Target: $6
Current: $1.78
Upside: +237.08%
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $9.14
Upside: +31.29%
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $7.05
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $1.40
Upside: +471.43%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.90
Upside: -
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $15.68
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $60
Current: $2.53
Upside: +2,272.48%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $8.08
Upside: +23.76%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $1.04
Upside: +383.09%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.80
Upside: +2,912.43%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $10.89
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $0.93
Upside: +114.02%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $0.80
Upside: +15,573.98%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.39
Upside: +1,702.27%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $39.79
Upside: -37.17%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.38
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $6,000 → $3,500
Current: $2.05
Upside: +170,324.11%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $2.85
Upside: +75.75%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.13
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $0.87
Upside: +244.87%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $16.18
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $120,000
Current: $3.93
Upside: +3,053,335.11%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $45.15
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.73
Upside: +99,087.22%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.35
Upside: -51.69%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $14.87
Upside: -